To prepare for the changes coming on 1st Jan 2025, Leah Heathman revisited the Windsor Framework, assessing its regulatory impact on your Marketing Authorisations and product packaging.
In this informative webinar, Leah addressed:
- A brief overview of the Windsor Framework’s background
- Impacts on Marketing Authorizations for medicines sold in the UK (Great Britain and Northern Ireland)
- Strategies for managing shared packs effectively
- Leveraging flexibilities provided by MHRA, HPRA, and EMA
- Submission requirements and updates for artwork
- Methods for mitigating large write-off costs and avoiding stock shortages
- Key guidance and recommended resources
Access the webinar recording and downloadable materials, including a consolidated Q&A, below:
Downloads: Webinar PDFQ&A PDF
